Detalhe da pesquisa
1.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-up From a Phase 3 Trial.
J Urol
; : 101097JU0000000000004020, 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704840
2.
Perioperative complications and oncological outcomes of open versus robotic-assisted radical cystectomy: a propensity score-matched study.
World J Urol
; 42(1): 220, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587653
3.
Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.
J Urol
; 209(4): 762-772, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583640
4.
Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.
J Urol
; 210(1): 54-63, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096575
5.
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.
J Urol
; 210(1): 46-53, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096582
6.
Unrecognized sexual dysfunction in gay and bisexual men after prostate cancer treatment: the antecedents and impact of anodyspareunia.
J Sex Med
; 20(4): 515-524, 2023 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796863
7.
Strategic Planning and Essential Steps for Establishing a Uterine Transplant and Rehabilitation Program: From Idea to Reality.
Ann Surg
; 276(1): 74-80, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793341
8.
Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review.
Cancer Causes Control
; 33(8): 1071-1081, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699798
9.
Diagnosing Prostate Cancer: The Role of Intravesical Prostatic Gland Protrusion on Accuracy of Prostate Biopsies.
J Urol
; 207(6): 1207-1213, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35080472
10.
Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons.
J Urol
; 207(3): 534-540, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694916
11.
Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry.
BJU Int
; 130(1): 62-67, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637596
12.
Creation and Psychometric Validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in Sexual Minority Patients-The Restore-2 Study.
J Sex Med
; 19(3): 529-540, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131199
13.
Recruiting an underserved, difficult to reach population into a cancer trial: Strategies from the Restore-2 Rehabilitation Trial for gay and bisexual prostate cancer patients.
Clin Trials
; 19(3): 239-250, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232299
14.
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
Lancet Oncol
; 22(7): 919-930, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051177
15.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253641
16.
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance.
Prostate
; 81(1): 41-49, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095939
17.
Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy.
J Urol
; 206(5): 1132-1138, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34184927
18.
The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma.
J Urol
; 206(6): 1380-1389, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348469
19.
Enhanced recovery after surgery (ERAS) following radical cystectomy: is it worth implementing for all patients?
World J Urol
; 39(6): 1927-1933, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32918095
20.
Making a case "against" focal therapy for intermediate-risk prostate cancer.
World J Urol
; 39(3): 719-728, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32529451